Effects of Growth Hormone Replacement Therapy on 1,25-Dihydroxyvitamin D and Calcium Metabolism*
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
To elucidate the changes in mineral metabolism and blood concentrations of calciotropic hormones which accompany GH therapy, we studied 12 GH-deficient children for 5 days before and for 1 week after high dose (5 IU/day) GH therapy, and again at 1 month, 3 months, and 1 yr of replacement therapy (0.1 IU/kg to a maximum dose of 2 IU three times weekly). All responded with acceleration of height velocity, and bone ages advanced appropriately. Fasting serum ionized calcium levels did not change: 4.11 +/- 0.06 (SEM) mg/dl before, 4.19 +/- 0.05 for the week of high dose therapy, and 4.20 +/- 0.14 during replacement therapy. Likewise, fasting serum parthormone did not vary: 38.9 +/- 2.6 muleq/ml before to 44.1 +/- 9.2 at 1 yr. Twenty four-hour nephrogenous cyclic AMP (NcAMP) did not vary over the first week (1.2 +/- 0.7 nmol/dl glomerular filtrate before, 1.3 +/- 0.4 after 1 week), but increased to 5.3 +/- 1.9 after 1 yr (alpha less than 0.001). The response of ionized calcium and parathormone to a standardized disodium EDTA infusion of 50 mg/kg also did not change. The mean fasting serum calcitonin level was not different before therapy (29.4 +/- 2.8 pg/ml), after 1 week (21.5 +/- 1.8), or after 1 yr (42.4 +/- 11.0). However, the mean serum 1,25-dihydroxyvitamin D concentration rose from 33.1 +/- 3.3 pg/ml before therapy to 68.3 +/- 12.3 on the seventh day of high dose therapy (alpha less than 0.01), returning to pretherapy values by 1 month. We conclude that high dose GH therapy in GH-deficient children raises 1,25-dihydroxyvitamin D concentration acutely, but that long term, physiological replacement therapy does not cause such an effect. Because NcAMP excretion rose in the absence of an increase in serum parathormone concentration, we conclude that GH sensitizes the kidney to a cAMP-mediated effect of parathormone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parathyroid Function and Vitamin D Metabolism during Human Growth Hormone Replacement*
GERTNER, J. M., HORST, R. L., BROADUS, A. E., RASMUSSEN, H., & GENEL, M. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-2-185 · Cited by 77
Cited by
Growth Hormone, Insulin-Like Growth Factors, and the Skeleton
Giustina, A., Mazziotti, G., & Canalis, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0036 · Cited by 914
Binnerts, A., Swart, G. R., Wilson, J. H. P., Hoogerbrugge, N., Pois, H. A. P., Birkenhager, J. C., & Lamberts, S. W. J. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02287.x · Cited by 315
Mazziotti, G., Frara, S., & Giustina, A. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00005 · Cited by 181
Savanelli, M. C., Scarano, E., Muscogiuri, G., Barrea, L., Vuolo, L., Rubino, M., Savastano, S., Colao, A., & Di Somma, C. (2016) · Endocrine · doi:10.1007/s12020-015-0779-3 · Cited by 59
“Vitamin D regulates gene expression of the GH/IGF-I axis and may promote the action of IGF-I by increasing IGF-I receptors, and both GH and IGF-I can elevate vitamin D concentrations by stimulating the hydroxylation in active hormone form [27–30].”
Background
Metadata
- Authors
- Burstein, S., Chen, I.-W., & Tsang, R. C.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1983-06
- Volume
- 56
- Issue
- 6
- Pages
- 1246-1251
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1976649572
- Cited by
- 57
- References
- 1
- FWCI
- 1.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of Growth Hormone Replacement Therapy on 1,25-Dihydroxyvitamin D and Calcium Metabolism*. https://app.cochat.ai/papers/10.1210/jcem-56-6-1246
- The paper
- Burstein, S., Chen, I.-W., & Tsang, R. C. (1983). Effects of Growth Hormone Replacement Therapy on 1,25-Dihydroxyvitamin D and Calcium Metabolism*. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jcem-56-6-1246
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.